oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes 🔴Cardiovascular with by severity of chronic kidney disease diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Clinical Effectiveness and Safety of

Patients can lose between 5% to 15% of their initial body weight over several months when adhering to the prescribed regimen.

"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes." New England Journal of Medicine 391.2 (2024): 109-121

Yes, IV vitamin therapy is generally safe when administered by trained medical professionals in a controlled environment

Achenie, L

While these changes are common for GLP-1 users, they can still feel frustrating when you feel like youre doing everything right. GLP-1 medications work by slowing digestion, which helps support feelings of fullness

Most people start to notice small changes such as a calmer mindset, slightly better sleep, or improved focus within the first two to four weeks of daily use